Ep125: Barry Greene on a New Drug for Depression
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
